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Abstract
Diet is a major modiﬁable lifestyle factor that may affect the components of the metabolic syndrome. We aimed to investigate the association
between relative proportions of macronutrients and the components of the metabolic syndrome in a population of individuals with type 1
diabetes. In all, 791 individuals without nephropathy, with plausible energy intake and known metabolic syndrome status, taking part in the
Finnish Diabetic Nephropathy Study were included in the analyses. Dietary data were collected with a diet record. The association between
the relative macronutrient intake and the outcome variables were analysed using multivariable nutrient density substitution models. The
relative proportions of dietary macronutrients or fatty acids were not associated with the presence of the metabolic syndrome. In men,
however, favouring carbohydrates over fats was associated with lower odds of the waist component, whereas favouring either carbohydrates
or fats over proteins was associated with lower odds of the blood pressure component of the metabolic syndrome. In women, substituting
carbohydrates for fats was associated with lower HDL-cholesterol concentration. Substituting carbohydrates or fats for alcohol or protein was,
in men, associated with lower systolic blood pressure. To conclude, the relative distribution of macronutrients may have some relevance for
the metabolic syndrome.
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The metabolic syndrome is a cluster of coexisting CVD risk factors
that include obesity, dyslipidaemia, hypertension and impaired
glucose metabolism(1). While the metabolic syndrome has
traditionally been associated with an increased risk of type 2
diabetes(2), clustering of these components is also frequent among
individuals with type 1 diabetes(3). Importantly, beyond traditional
risk factors, the presence of the metabolic syndrome substantially
increases the risk of cardiovascular events, and cardiovascular-
and diabetes-related mortality in this population(4).
Lifestyle changes, such as dietary modiﬁcations, should be
the ﬁrst line of treatment upon the emergence of cardiometa-
bolic risk factors(5). Importantly, it has been shown that a
comprehensive lifestyle intervention may improve all compo-
nents of the metabolic syndrome and also prevent the occur-
rence of type 2 diabetes(6). Diet is a major modiﬁable lifestyle
factor. According to the American Diabetes Association current
evidence does not, however, support one ideal dietary
macronutrient distribution that would apply for all individuals
with diabetes(7). Instead, the macronutrient distribution should
be based on individualised assessment of current eating pat-
terns, preferences and metabolic goals. In practice, however,
the role of carbohydrates over other macronutrients is often
emphasised, as seen in the current Finnish dietary recommen-
dations, where the recommended proportion of carbohydrates
is between 45 and 60% of total energy intake(8). For individuals
with diabetes, it is important to note that the intake of carbo-
hydrates raises the blood glucose concentrations. Moreover, the
intake of carbohydrates, rather than fats, has been associated
with a less favourable blood lipid panel both in a cross-sectional
setting(9) and following a 3-week intervention(10).
The association between macronutrient intake and the meta-
bolic syndrome has been evaluated in a number of studies(11–14).
No studies, to our knowledge, have however been conducted
among individuals with type 1 diabetes, a population with a high
Abbreviations: E%, percentages of total energy; LTPA, leisure-time physical activities.
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risk of cardiovascular complications. Moreover, the methods
used in these studies differ substantially from one study to
another. Importantly, when studying the associations between
health markers and macronutrient intake, it should be noted that
an increase in the intake of one macronutrient is, in isoenergetic
conditions, always accompanied by a decrease in the intake of
another macronutrient. To our knowledge, only one study has
taken such an isoenergetic substitution into consideration(11).
Therefore we studied the association between macronutrient
intake and the metabolic syndrome, using a multivariable nutri-
ent density substitution model, in a population of well-deﬁned
individuals with type 1 diabetes, who are at an increased risk
of CVD.
Methods
The study subjects were participants in the Finnish Diabetic
Nephropathy (FinnDiane) Study. The FinnDiane Study, launched
in 1997, was established with the aim to identify factors
associated with the emergence of diabetic complications, espe-
cially that of diabetic nephropathy, in individuals with type 1
diabetes. Since the beginning of the study, baseline data have
been collected from more than 5000 individuals. The diet
sub-study was not, however, introduced until 2007. In the cur-
rent cross-sectional analyses, we included all FinnDiane Study
participants without diabetic nephropathy, and who had com-
pleted a minimum of 3-d diet record with plausible energy intake
((5439–14644kJ/d) 1300–3500kcal/d), within 2 years from their
study visit and whose metabolic syndrome status could be
deﬁned (n 791). The study protocol was approved by the Ethics
Committee of the Helsinki University Central Hospital. Study
subjects provided written informed consent before participation.
Subjects’ dietary intake was evaluated using two separate
methods, as previously described(15). First, during the study
visit, participants were given a self-administered diet ques-
tionnaire. With this form, we aimed at collecting data on the
participants’ habitual dietary intake. The form included ques-
tions regarding the consumption of some of the most typical
food items in Finland such as coffee, milk, bread, ﬁsh, meat,
poultry, eggs, vegetables, and fruits and berries. Next, the par-
ticipants were sent a 3-d exercise and diet record together with
detailed instructions. In this record participants reported all
foods and drinks consumed during the allocated consecutive
days. Moreover, in the same form, leisure-time physical
activities (LTPA), blood glucose measurements, and insulin
administrations were reported. Another 3-d exercise and food
record was completed after 10 weeks from the ﬁrst record. Up
to two reminders were sent to the non-responders. Dietary
composition was analysed using the Diet 3.2 software (version
1.4.6.2; AIVO) and, from August 2014 onwards, AivoDiet
software (version 2.0.2.3; AIVO), which both are based on the
Finnish National Food Composition Database, Fineli. For the
current analyses, percentages of total energy (E%) derived from
the macronutrients were calculated. The proportion of energy
derived from trans-fatty acids was estimated as the difference
between total fat and the sum of SFA, MUFA and PUFA.
Therefore, trans-fatty acids were only used to adjust the
models, and not as an independent variable.
Height and weight were measured in light clothing, and these
measurements were used to calculate BMI (kg/m2). Waist
circumference was measured midway between the lowest rib
and the iliac crest. Following a minimum of 10-min rest, blood
pressure was measured while seated. The measurement was
repeated after a 2-min interval, and the mean of these two
measurements was used in the analyses. HbA1c was determined
locally using standardised assays. Serum lipid and lipoprotein
concentrations were measured centrally at the research
laboratory of the Helsinki University Central Hospital. Serum
TAG concentration was measured using a Konelab 60i analyser
(Thermo Fisher Scientiﬁc Inc.), and serum HDL-cholesterol
concentration was measured using a HTS 7000 plus Bio
Assay Reader (PerkinElmer Inc.). Renal status was assessed on
the basis of urinary albumin excretion rate (AER) in at least two
out of three timed 24-h or overnight urine collections. Included
in the analyses were individuals with normal AER (<20 μg/min
or <30mg/24 h) or microalbuminuria (AER≥ 20 and <200 μg/
min or ≥30 and <300mg/24 h). Those with diabetic nephro-
pathy (AER≥ 200 μg/min or ≥300mg/24 h, undergoing dialysis
or having a kidney transplant) were excluded from the ana-
lyses, as such a diagnosis could affect both the dietary intake
and the components of the metabolic syndrome. Smoking and
social class (grouped as unskilled/skilled blue collar, upper/
lower white collar, farmers and others) were self-reported.
Unskilled blue-collar workers were classiﬁed as low socio-
economic status.
LTPA was estimated using a validated questionnaire, as
previously described(16). As part of this questionnaire, using an
eight-level scale, participants were asked to report how
frequently they typically take part in LTPA (never, occasionally,
1–3 times a month, once a week, twice a week, three times
a week, 4–5 times a week, more frequently). For the analyses,
the population was divided into two, using the median
reported frequency (those taking part in LTPA twice a week or
less often, and those taking part in LTPA at least three times
per week).
The criteria established by the International Diabetes Fede-
ration Task Force on Epidemiology and Prevention; National
Heart, Lung, and Blood Institute; American Heart Association;
World Heart Federation; International Atherosclerosis Society;
and International Association for the Study of Obesity(1) were
used to deﬁne the metabolic syndrome. According to these
criteria, the metabolic syndrome is present if at least three of the
following criteria co-exist: waist circumference ≥94 cm in men
and ≥80 cm in women; blood pressure ≥130/85mmHg or the
use of antihypertensive medication; TAG concentration
≥1·70mmol/l or medication to treat high TAG concentration;
HDL-cholesterol concentration in men <1·0mmol/l and in
women <1·3mmol/l or medication to treat reduced HDL-
cholesterol concentration; and fasting glucose ≥6·11mmol/l. As
all participants were diagnosed with type 1 diabetes, they were
all deﬁned to fulﬁl the criterion for hyperglycaemia. The
metabolic syndrome and the individual criteria were treated as
dichotomous variables in the analyses. Moreover, the blood
pressure measurements, TAG concentration, HDL-cholesterol
concentration and waist circumference were treated as
continuous variables.
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Statistical analyses
Descriptive statistics are reported as mean values and standard
deviations for continuous normally distributed data, median and
interquartile ranges for continuous non-normally distributed
data and percentages for categorical data. The respective
between-group comparisons were conducted with independent
samples t test, Mann–Whitney U test, and χ2 test.
To examine the associations between the macronutrient
intakes and the outcome variables, multivariable nutrient density
substitution models were used as described elsewhere(11). In
brief, dichotomised outcome variables were entered as depen-
dent variables in the logistic regression analyses, whereas
continuous variables were analysed using generalised linear
regression. Included, in each model at a time, were all but one
macronutrient (per 5 E%), total energy intake, and selected
variables as cofactors. The results can be interpreted as the
increase or decrease in the outcome variable related to the iso-
energetic (5 E%) substitution of a given macronutrient in the
model with the macronutrient left out from the model. Thus, for
example, in an equation: HDL-cholesterol concentration= β0 + β1
(5 E% from carbohydrates) + β2 (5 E% from fats) + β3 (5 E% from
alcohol) + β4 (kJ (kcal)), β1 would be interpreted as the change in
the HDL-cholesterol concentration when dietary carbohydrate
intake is increased by 5E% at the expense of proteins.
A two-tailed P value<0·05 was considered statistically
signiﬁcant. All data were analysed using IBM SPSS Statistics for
Windows, version 22.0 (IBM Corp.).
Results
Those with the metabolic syndrome were older, had a longer
diabetes duration, and worse glycaemic control (Table 1).
Women with the metabolic syndrome were more frequently
current smokers and were less physically active compared with
women without the metabolic syndrome. Those with the
metabolic syndrome reported lower energy intake, but the
macronutrient distribution did not differ between those with
and without the metabolic syndrome (Table 2).
Using the macronutrient substitution approach, the relative
proportions of dietary macronutrients were not associated with
the presence of the metabolic syndrome in either men or
women (Table 3). However increased carbohydrate intake, at
the expense of fats, was associated with lower odds of fulﬁlling
the waist component of the metabolic syndrome, in men (as a
note, the results of the multivariable models may also be
interpreted reversely, thus here, increased intake of fat at the
expense of carbohydrates, is associated with higher odds of
fulﬁlling the waist component). Also in men, substituting
carbohydrates or fats for proteins reduced the odds of the blood
pressure component of the metabolic syndrome. In women, no
associations between macronutrient substitutions and the
metabolic syndrome or its components were observed.
Moreover, substituting between different fatty acids was not
associated with the presence of these outcome variables (online
Supplementary Table S1).
In men, replacement of fat with carbohydrate was
associated with lower waist circumference and lower TAG Ta
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Table 2. Energy and macronutrient intake of the study population divided by sex and the metabolic syndrome status
(Mean values and standard deviations; medians and interquartile ranges (IQR))
Men (MetS) Women (MetS)
No (n 136 (41·5%)) Yes (n 192 (58·5%)) No (n 203 (43·8%)) Yes (n 260 (56·2%))
Median IQR Median IQR P Median IQR Median IQR P
Energy (MJ) 0·011 7·6 6·8–8·6 7·2 6·4–8·2 0·003
Mean 9·5 9·0
SD 1·9 1·9
Energy (kcal) 0·011 1810 1615–2064 1713 1519–1968 0·003
Mean 2271 2139
SD 453 464
Carbohydrate (E%) 44·6 40·2–48·7 43·3 38·9–48·0 0·097 0·367
Mean 44·3 43·8
SD 6·6 6·6
Protein (E%) 15·9 14·6–18·2 16·6 14·9–18·3 0·115 16·3 14·5–18·4 16·8 15·0–18·3 0·264
Total fat (E%) 0·187 0·898
Mean 34·5 35·5 35·2 35·1
SD 5·0 7·1 6·2 5·9
SFA (E%) 12·1 10·4–14·2 12·4 10·6–14·4 0·603 0·391
Mean 12·7 12·5
SD 3·1 2·9
MUFA (E%) 11·3 10·2–13·2 11·6 10·0–13·4 0·472 11·4 10·3–13·2 11·7 10·2–13·4 0·733
PUFA (E%) 5·4 4·8–6·3 5·7 4·9–6·6 0·073 5·8 4·8–6·8 5·6 4·9–6·9 0·980
Alcohol (E%) 1·5 0–4·4 1·4 0–3·9 0·861 0·7 0–2·7 1·0 0–3·3 0·449
MetS, metabolic syndrome; E%, percentage of total energy intake.
Table 3. Association between dietary macronutrient intake (substitution model) and the metabolic syndrome and its individual components (as dichotomous variables)†
(Odds ratios and 95% confidence intervals)
Macronutrients intake
MetS Waist TAG HDL BP
increased (reduced) OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
CHO (protein) M 0·755 0·443, 1·288 0·930 0·558, 1·551 0·833 0·500, 1·389 0·706 0·419, 1·189 0·377* 0·160, 0·888
W 1·262 0·846, 1·883 0·990 0·672, 1·459 1·308 0·829, 2·065 1·159 0·763, 1·761 0·989 0·652, 1·498
CHO (fat) M 0·969 0·781, 1·203 0·795* 0·640, 0·988 0·857 0·693, 1·061 1·003 0·808, 1·247 1·166 0·864, 1·574
W 1·135 0·916, 1·405 0·971 0·787, 1·197 1·006 0·799, 1·266 1·018 0·820, 1·265 1·242 0·987, 1·565
CHO (alcohol) M 0·895 0·631, 1·269 0·951 0·675, 1·341 0·770 0·545, 1·088 0·885 0·622, 1·260 0·692 0·399, 1·200
W 1·014 0·672, 1·531 1·061 0·715, 1·572 0·957 0·632, 1·450 0·868 0·584, 1·289 0·928 0·587, 1·467
Fat (protein) M 0·799 0·452, 1·412 1·178 0·683, 2·032 0·987 0·573, 1·700 0·734 0·422, 1·276 0·336* 0·133, 0·847
W 1·134 0·745, 1·727 1·049 0·699, 1·574 1·318 0·816, 2·130 1·158 0·746, 1·798 0·800 0·513, 1·247
Fat (alcohol) M 0·934 0·642, 1·358 1·199 0·829, 1·734 0·910 0·632, 1·312 0·901 0·618, 1·314 0·598 0·337, 1·062
W 0·929 0·599, 1·441 1·123 0·736, 1·713 0·989 0·627, 1·560 0·888 0·578, 1·363 0·754 0·465, 1·223
Protein (alcohol) M 1·310 0·726, 2·364 1·074 0·616, 1·873 0·987 0·566, 1·720 1·468 0·824, 2·617 2·046 0·789, 5·302
W 0·873 0·494, 1·543 1·195 0·695, 2·057 0·795 0·443, 1·426 0·808 0·464, 1·407 0·929 0·499, 1·729
MetS, metabolic syndrome; Waist, waist component of the metabolic syndrome; TAG, TAG component of the metabolic syndrome; HDL, HDL-cholesterol component of the metabolic syndrome; BP, blood pressure component of the
metabolic syndrome; CHO, carbohydrate; M, men; W, women.
* P<0·05.
† Logistic regression analyses. All models are adjusted for age, smoking and physical activity. In each model, a given macronutrient is included as an independent variable and one of the macronutrients (in the parentheses) is excluded
from the model. The remaining macronutrients and total energy intake are included as covariates. The OR represent the increase or decrease in the risk of having the metabolic syndrome or one of its individual components when
increasing the intake of the independent macronutrient by 5% of total energy, while simultaneously reducing an isoenergetic amount of the excluded macronutrient.
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concentration (Table 4). Lower HDL-cholesterol concentrations
were observed when energy from alcohol was replaced with
carbohydrates or fats. Lower systolic blood pressure, on the
other hand, was observed when carbohydrate or fat were
substituted for protein or alcohol. Finally, reducing alcohol
while increasing fat intake was associated with lower diastolic
blood pressure. In women, substituting carbohydrate for fats or
alcohol, was associated with lower HDL-cholesterol con-
centration (Table 4). Substitutions between different fatty acids
were not associated with any of the continuous outcome vari-
ables studied (online Supplementary Table S2).
Discussion
In the current study, in a group of well-deﬁned individuals with
type 1 diabetes, the relative distribution of dietary macro-
nutrients was not associated with the presence of the metabolic
syndrome. The substitution models showed that in men,
favouring carbohydrates over fats was, however, associated
with a lower prevalence of the waist component, while
favouring either carbohydrates or fats over proteins was
associated with a lower prevalence of the blood pressure
component of the metabolic syndrome.
To our knowledge this is the ﬁrst study to investigate the
relative macronutrient distribution and the metabolic syndrome
among individuals with type 1 diabetes. The cross-sectional
nature of the study, however, prohibits any conclusions about
the temporal relationships between the macronutrient intake
and the health variables. Therefore, the observed results do not
necessarily indicate that eating carbohydrates would be more
slimming than eating fats, for example. The cause and effect
could also be reversed as a low-carbohydrate–high-fat diet has
successfully been used as a method of weight reduction(14,17).
Therefore, it could be possible that those with larger waist
circumferences have rather switched to such a diet in order to
lose weight. A meta-analysis of three population-based studies
with a total of 12 342 individuals, however, reported that the
likelihood of being obese was the lowest in the highest quartile
of total carbohydrate intake(18). Similarly, although the current
research evidence does not support it(19), it is also possible that
individuals with hypertension have reduced their protein
intake, in hope of managing their blood pressure.
In isoenergetic conditions, reduced intake of a given
macronutrient is accompanied by a simultaneous increase in
the intake of one or several of the remaining macronutrients. As
macronutrients utilise different metabolic pathways, the
macronutrient composition of the diet may be of importance,
particularly in studies related to the metabolic syndrome. We
have been able to identify only one such previous study, in the
ﬁeld of the metabolic syndrome, where the macronutrient
substitution was considered. Indeed, using multivariable nutri-
ent density substitution models, in a population of individuals
with high cardiovascular risk, Skilton et al.(11) observed that an
isoenergetic increase in fat intake, at the expense of protein,
was associated with a decrease in the prevalence of the
metabolic syndrome. Reduced risk of the metabolic syndrome
was also observed when carbohydrates were substituted for
either fats or proteins.Ta
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Regarding the continuous outcome variables, in the present
study, favouring carbohydrates over fats was, in women,
associated with lower HDL-cholesterol concentrations. This
observation was also made, not only in the study by Skilton
et al.(11), but also in another study among healthy individuals
free of any major medical problems(20). Consistent with our
observations among men, Skilton et al.(11) reported that sub-
stituting carbohydrates for fats was associated with lower odds
of fulﬁlling the waist circumference criterion of the metabolic
syndrome. In their study, however, favouring carbohydrates or
fats over proteins was also associated with reduced odds of the
waist component. Moreover, in their population, consumption
of up to 1 standard alcohol drink/d was associated with a lower
prevalence of the metabolic syndrome when compared with
non-drinkers. Finally, similar to us, Skilton et al. observed no
association between the proportion of dietary fatty acids and
the metabolic syndrome or its components.
In the current study, substituting carbohydrates (in men and
women) or fats (in men) for alcohol was also associated with
lower HDL-cholesterol concentrations. A beneﬁcial effect of
moderate alcohol consumption on HDL-cholesterol has also
previously been reported(21). On the other hand, higher alcohol
or protein consumption, over fats or carbohydrates was, in men,
associated with higher systolic blood pressure. The positive
association between alcohol intake and blood pressure, has
also been previously reported(22). Finally, substitution of
carbohydrates with fats was associated with lower TAG con-
centrations, in men. This observation is not in concordance with
any previous reports, which have shown higher TAG con-
centrations with higher carbohydrate intakes(11,14). While the
reason behind this difference is not known, it can be speculated
that different study populations might contribute. Compared
with other populations, those with type 1 diabetes may, for
example, be more readily treated with lipid lowering agents.
Moreover, as previously shown, the mean intake of carbo-
hydrates in the FinnDiane population is low(15), and could be
lower than in other populations.
A number of other studies, although not using the multi-
variable nutrient density substitution model, have also been
conducted to reveal the associations between dietary macro-
nutrient intake and the metabolic syndrome. In one such study,
Freire et al.(13) observed that total fat intake was positively
associated with the presence of the metabolic syndrome in
Japanese Brazilians. In a population of American Indians, PUFA
intake in women and simple carbohydrate intake in men was
associated with lower and higher prevalence of the metabolic
syndrome, respectively(23). Yet in another study, a wealthier
intake of PUFA and ﬁbre, among subjects with high CVD risk,
was associated with reduced odds of the metabolic
syndrome(24). Finally, in the cross-sectional analyses of the
Framingham Offspring Study, total carbohydrate intake, mea-
sured with a semi quantitative FFQ, was not associated with the
prevalence of the metabolic syndrome(12).
There are a number of limitations related to the current study
that need to be acknowledged. First, the use of diet record has
its limitations. The very act of reporting dietary intake may result
in over- or under-reporting food items that are considered
healthy and unhealthy, respectively. In addition, although
truthfully reporting their dietary intake, during the allocated
days, subjects may still have altered their food intake for the
duration of record-keeping to reﬂect more socially acceptable
dietary habits. Should these phenomena have taken place, they
have most likely diluted the current observations. Second, as is
the case in many other studies, our study is limited by potential
selection bias. Thus, participants in health related studies are
likely to be over-represented by health-conscious individuals,
with healthier lifestyle and, in our case, potentially less pre-
valent metabolic syndrome. Again, should this have taken
place, it would have only diluted the results. Third, typical to
observational studies, we cannot rule out the possibility of
residual confounding. Fourth, while the use of a substitution
model is justiﬁed when studying the health effects of different
macronutrients in isoenergetic conditions, it has to be
acknowledged that this approach is only a mathematical model
for dietary intake and not a real-life condition. Moreover, diet is
more than just macronutrients. In these analyses the intake of
items such as ﬁbre, vitamins and minerals from different food
sources are not taken into account. Finally, this was a cross-
sectional study, which does not reveal causalities, but only
associations. In the future, the prospective associations between
the dietary intake and the metabolic syndrome will be assessed.
In conclusion, relative macronutrient distribution was not
associated with the presence of the metabolic syndrome in
type 1 diabetes. In men, a diet with more abundant intake of
carbohydrates over fats was associated with lower odds of
fulﬁlling the waist component, while substituting carbohydrates
or fats for proteins was associated with lower odds of fulﬁlling
the blood pressure component of the metabolic syndrome. To
reveal potential causalities between different macronutrient
intakes and health variables, prospective studies in real-life
circumferences are needed.
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